Identification of ortho-hydroxy anilide as a novel scaffold for lysine demethylase 5 inhibitors
P Jaikhan, B Buranrat, Y Itoh, J Chotitumnavee… - Bioorganic & Medicinal …, 2019 - Elsevier
Abstract Fe (II)/α-ketoglutarate-dependent lysine demethylases (KDMs) are attractive drug
targets for several diseases including cancer. In this study, we designed and screened ortho …
targets for several diseases including cancer. In this study, we designed and screened ortho …
Strategies of polypharmacology
Z Wang, B Yang - Polypharmacology: Principles and Methodologies, 2022 - Springer
In Chap. 1, we have learned that the modern pharmacological therapy of human disease
and new drug discovery are based primarily on four major strategies/modality: the STD …
and new drug discovery are based primarily on four major strategies/modality: the STD …
[HTML][HTML] 组蛋白甲基转移酶SUV4-20H 的研究进展
赵丹洋, 姜红, 姜红堃 - 中国医科大学学报, 2020 - html.rhhz.net
组蛋白甲基转移酶SUV4-20H 为哺乳动物组蛋白H4 第20 位赖氨酸(H4K20)
的特异性甲基转移酶, 在人体组织中广泛表达. SUV4-20H 蛋白本身及其介导的H4K20 …
的特异性甲基转移酶, 在人体组织中广泛表达. SUV4-20H 蛋白本身及其介导的H4K20 …
Modulation of DNA/RNA Methylation by Small-Molecule Modulators and Their Implications in Cancer
Chromatin is an organized complex of DNA, histone proteins, and RNA. Chromatin
modifications include DNA methylation, RNA methylation, and histone acetylation and …
modifications include DNA methylation, RNA methylation, and histone acetylation and …
Epigenetic control using small molecules in cancer
Epigenetics is defined as heritable alterations in gene expression that are not caused by
changes in DNA sequence. Such normal alterations are vital for appropriate differentiation …
changes in DNA sequence. Such normal alterations are vital for appropriate differentiation …
[PDF][PDF] Mitochondria and Cancer Pathogenesis–The role of Reactive Oxygen Species (ROS) Production, Apoptosis, and Epigenetics: A Review
NA Chrysanthakopoulos, E Vryzaki - 2022 - researchgate.net
■ Abstract Mitochondria are metabolic organelles responsible for cellular functions such as
development, division, energy metabolism by oxidative phosphorylation (OXPHOS) …
development, division, energy metabolism by oxidative phosphorylation (OXPHOS) …
[PDF][PDF] Modulatoren epigenetischer Regulationsmechanismen: Medizinische Chemie neuer KDM4-Inhibitoren und Methodenentwicklung zur SFC-MS-Analytik von …
GM Fassauer - 2018 - epub.ub.uni-greifswald.de
Die Zusammenhänge zwischen der Aktivität Epigenetik-assoziierter Enzyme und
Krankheitsgeschehen neoplastischer Art konnten nicht nur experimentell bestätigt, sondern …
Krankheitsgeschehen neoplastischer Art konnten nicht nur experimentell bestätigt, sondern …
Modus operandi of COMPASS/MLL epigenetic writers in the mammalian genome
D Bayarsaihan - Epigenomics, 2018 - Taylor & Francis
The COMPASS/MLL family of H3K4 methyltransferases is highly conserved throughout the
eukaryotic kingdom [1]. MLL4 (KMT2D) is a main H3K4 methyltransferase responsible for …
eukaryotic kingdom [1]. MLL4 (KMT2D) is a main H3K4 methyltransferase responsible for …
[PDF][PDF] Structural view on the role of TRD loop in regulating DNMT3A activity: a molecular dynamics study
Z Wang, Y Kang - researchgate.net
DNA methyltransferase 3A (DNMT3A) has been regarded as a potential epigenetic target for
the development of cancer therapeutics. A number of DNMT3A inhibitors have been …
the development of cancer therapeutics. A number of DNMT3A inhibitors have been …
[HTML][HTML] Mimicking the Nucleosomal Context in Peptide-Based Binders of a H3K36me Reader Increases Binding Affinity While Altering the Binding Mode
V Horn, SAK Jongkees, H van Ingen - Molecules, 2020 - mdpi.com
Targeting of proteins in the histone modification machinery has emerged as a promising
new direction to fight disease. The search for compounds that inhibit proteins that readout …
new direction to fight disease. The search for compounds that inhibit proteins that readout …